𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The efficacy of pyrimethamine-sulfadoxine (Fansidar®) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children

✍ Scribed by B.R. Ogutu; B.L. Smoak; R.W. Nduati; D.A. Mbori-Ngacha; F. Mwathe; G.D. Shanks

Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
294 KB
Volume
94
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sulfadoxine-pyrimethamine for the treatm
Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children
✍ P. Deloron; J. Mayombo; A. Le Cardinal; J. Mezui-Me-Ndong; C. Bruzi-Baert; F. Le 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Chloroquine can no longer be recommended as the first-line treatment for falciparum malaria in several parts of Africa, given the increasing resistance of Plasmodium falcipanrm to this drug. The sulfadoxinepyrimethamine combination (SP) is obviously an alternative candidate, that has already been se

Comparative efficacy of chloroquine plus
Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children
✍ A. Sowunmi; A.M.J. Oduola; O.A.T. Ogundahunsi; L.A. Salako 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 647 KB

The efficacy of pyrimethamineisulfadoxine (I'S) and chloroquine plus chlorpheniramine, a histamine H1 receptor blocker which reverses chloroquine insensitivity in Plasmodium falciparum in vitro, was evaluated in 100 consecutive children with acute symptomatic uncomplicated falciparum malaria. Parasi

A randomized safety and tolerability tri
A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children
✍ J.F. Doherty; A.D. Sadiq; L. Bayo; A. Alloueche; P. Olliaro; P. Milligan; L. von 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 474 KB

Artemisinin derivatives, such as artesunate, have a short half-life and very rapid anti-malarial activity. Theoretically, using such agents in conjunction with well-established anti-malarial drugs such as sulfadoxine-pyrimethamine may reduce the rate of drug resistance. Such a combination has not pr

A trial of Fansidar® plus chloroquine or
A trial of Fansidar® plus chloroquine or Fansidar® alone for the treatment of uncomplicated malaria in Gambian children
✍ K.A. Bojang; G. Schneider; S. Forck; S.K. Obaro; S. Jaffar; M. Pinder; J. Rowley 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 537 KB

Chloroquine can no longer be recommended as the first-line treatment for uncomplicated malaria in several parts of Africa because of the increasing prevalence of chloroquine resistance. However, chloroquine was a highly effective treatment for malaria not only because of its ability to kill parasite